J9 Era

نویسندگان

  • E. Aoustin
  • A. I. Schäfer
  • A. G. Fane
  • T. D. Waite
چکیده

Increasingly stringent regulations for drinking water quality have stimulated the application of ultrafiltration to water treatment. In addition to removing particulate materials from water (including microorganisms, bacteria and viruses), the use of membrane treatment also meets purification requirements. However, irreversible fouling curtails the economic viability of such a process. Experiments in stirred-cells were conducted to evaluate the effects of surface water composition on rejection and fouling of two ultrafiltration membranes with different molecular weight cut-offs (10kDa and 100kDa). Experimental solutions consisted of natural organic matter or humic substances in a background electrolyte. The effect of calcium concentration decreased rejection of humic acid under certain circumstances. This is believed due to reduced molecular size with an initial increase in calcium concentration. However, at about 2.5mM CaCl2, IHSS humic acid aggregates. This aggregation increased rejection, and also caused irreversible fouling of the 100kDa membrane, presumably as a result of pore size reduction due to internal deposition of aggregates. This was confirmed by blocking law analysis. The variation of transmembrane pressure indicated the importance of a ‘critical flux’ effect. The organics and their various fractions showed differences both in rejection and flux decline. The larger and more UV-absorbing fraction of humic acid was shown to be responsible for irreversible pore adsorption and plugging. The fulvic acid and the hydrophilic fraction showed a smaller and mostly reversible flux decline.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

New therapy with ASC-J9® to suppress the prostatitis via altering the cytokine CCL2 signals

Prostatitis is a common disease contributing to 8% of all urologist visits. Yet the etiology and effective treatment remain to be further elucidated. Using a non-obese diabetes mouse model that can be induced by autoimmune response for the spontaneous development of prostatitis, we found that injection of the ASC-J9® at 75 mg/Kg body weight/48 hours led to significantly suppressed prostatitis t...

متن کامل

Sorafenib with ASC‐J9® synergistically suppresses the HCC progression via altering the pSTAT3‐CCL2/Bcl2 signals

Sorafenib is currently used as a standard treatment to suppress the progression of hepatocellular carcinoma (HCC), especially in advanced stages. However, patients who receive Sorafenib treatment eventually develop resistance without clear mechanisms. There is a great need for better efficacy of Sorafenib treatment in combination with other therapies. Here, we demonstrated that the treatment co...

متن کامل

Antiandrogen Therapy with Hydroxyflutamide or Androgen Receptor Degradation Enhancer ASC-J9 Enhances BCG Efficacy to Better Suppress Bladder Cancer Progression.

Recent studies suggest that the androgen receptor (AR) might play important roles in influencing bladder cancer progression, yet its clinical application remains unclear. Here, we developed a new combined therapy with Bacillus Calmette-Guérin (BCG) and the AR degradation enhancer ASC-J9 or antiandrogen hydroxyflutamide (HF) to better suppress bladder cancer progression. Mechanism dissection rev...

متن کامل

Targeting inflammatory cytokines-androgen receptor (AR) signaling with ASC-J9® to better battle prostate cancer progression

Inflammatory cytokines and chemokines released by macrophages in the prostate cancer microenvironment may signal via the androgen receptor (AR) to influence tumor progression. In particular, macrophages appear to promote tumorigenesis by altering the chemokine (C-C motif) ligand 4 (CCL4)/AR signaling axis. This process can be blocked by ASC-J9®, an enhancer of AR degradation. ASC-J9® also inhib...

متن کامل

Small Molecule Therapeutics Antiandrogen Therapy with Hydroxyflutamide or Androgen Receptor Degradation Enhancer ASC- J9 Enhances BCG Efficacy to Better Suppress Bladder Cancer Progression

Recent studies suggest that the androgen receptor (AR) might play important roles in influencing bladder cancer progression, yet its clinical application remains unclear. Here, we developed a new combined therapy with Bacillus Calmette–Gu erin (BCG) and the AR degradation enhancer ASC-J9 or antiandrogen hydroxyflutamide (HF) to better suppress bladder cancer progression. Mechanism dissection re...

متن کامل

Npgrj_NM_1547 348..353

Motor neuron degeneration resulting from the aggregation of the androgen receptor with an expanded polyglutamine tract (AR-polyQ) has been linked to the development of spinal and bulbar muscular atrophy (SBMA or Kennedy disease). Here we report that adding 5-hydroxy-1,7-bis(3,4-dimethoxyphenyl)-1,4,6-heptatrien-3-one (ASC-J9) disrupts the interaction between AR and its coregulators, and also in...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2010